Please join ITIF for the latest in a series of discussions on “dynamic antitrust.” In this installment, Julie Carlson will sit down with former chief economists from the DOJ and FTC to discuss their views on the planned revisions to the guidelines.
How have the U.S. and global life-sciences innovation ecosystems been so successful in facilitating the rapid development of COVID-19 vaccines and therapeutics to help global society navigate the pandemic? The answer begins with decades of U.S.
Please join ITIF, Geneva Network, Hudson Institute, the Center for Intellectual Property and Innovation Protection, Property Rights Alliance, and the U.S. Chamber of Commerce as we learn the stories of a few of the individuals and SMEs who rely on IP rights to innovate for a better future.
Mapping people’s movements can be an invaluable first step in addressing a wide range of pressing societal challenges.
ITIF’s Schumpeter Project on Competition Policy and George Washington University’s Regulatory Studies Center co-hosted a special conference for antitrust scholars and practitioners to gather and reflect on the Schumpeterian approach to antitrust as we paid tribute to Jerry Ellig’s seminal work on dynamic antitrust.
Please join ITIF’s Schumpeter Project on Competition Policy and the Classical Liberal Institute at NYU School of Law for a joint conference to discuss the shifting antitrust paradigm and its implications for the rule of law and innovation.
In the aftermath of Putin’s invasion of Ukraine, a new iron curtain has descended on Russia’s Internet, with a multitude of social networks, online services, and payment services, either leaving the Russian market entirely or imposing significant restrictions on their services.
Please join ITIF for the latest in a series of discussions on “dynamic antitrust,” in which ITIF’s Schumpeter Project on Competition Policy hosts leading scholars and antitrust enforcers to discuss the path forward in making antitrust a foundation for innovation.
ITIF hosted a panel discussion with leading experts on innovation policy, technology transfer, and business, who spoke to the practical implications of exercising federal “march-in” rights and why it would be a grave and ill-timed mistake for the U.S. health, competitiveness, and research landscape.
Watch ITIF’s Center for Data Innovation for a conversation with Ben Shneiderman, whose new book calls for a “human-centered” perspective on AI, as opposed to a “technology-centered” focus, so as to better serve human needs.